According to new research looking at every U.S. state, programs that deliver medically tailored meals (MTMs) to people with diet-sensitive conditions such as diabetes and heart disease along with limitations in the ability to perform daily activities could lead to substantial savings in healthcare costs.
Gene Therapies for Neovascular AMD Continue to Show Promise
STOCKHOLM — Two VEGF-targeting gene therapies for neovascular age-related macular degeneration (nAMD) substantially reduced treatment burden while preserving visual acuity, according to results reported here.
July 19, 2024